The IL-36y is potential biomarker of psoriatic erythroderma
- Authors: Zaslavsky D.V.1, Sydikov A.A1, Chuprov I.N2, Ibragimov K.U1, Nasyrov R.A1, Egorova Y.S1, Khvedelidze M.G1, Wenzel J.3
-
Affiliations:
- St. Petersburg State Pediatric Medical University
- I.I. Mechnikov NorthWestern State Medical University
- Rheinische Friedrich-Wilhelm-University
- Issue: Vol 18, No 5 (2015)
- Pages: 30-33
- Section: Articles
- URL: https://journals.rcsi.science/1560-9588/article/view/36986
- DOI: https://doi.org/10.17816/dv36986
- ID: 36986
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Denis V. Zaslavsky
St. Petersburg State Pediatric Medical University
Email: venerology@gmail.com
MD, PhD, DSc, prof. 194100, St. Petersburg, Russia
A. A Sydikov
St. Petersburg State Pediatric Medical Universityкандидат мед. наук, врач-дерматолог 194100, St. Petersburg, Russia
I. N Chuprov
I.I. Mechnikov NorthWestern State Medical Universityдоктор мед. наук, доцент 191015, St. Petersburg, Russia
K. U Ibragimov
St. Petersburg State Pediatric Medical Universityврач-патологоанатом 194100, St. Petersburg, Russia
R. A Nasyrov
St. Petersburg State Pediatric Medical Universityдоктор мед. наук, профессор 194100, St. Petersburg, Russia
Yu. S Egorova
St. Petersburg State Pediatric Medical Universityкандидат мед. наук, доцент 194100, St. Petersburg, Russia
M. G Khvedelidze
St. Petersburg State Pediatric Medical Universityассистент, врач-дерматолог 194100, St. Petersburg, Russia
Jorg Wenzel
Rheinische Friedrich-Wilhelm-UniversityUniversity Clinic of Bonn 53105 Bonn, Germany
References
- Vonderheid E.C., Bernengo M.G., Burg G., Duvic M., Heald P., Laroche L., et al.; ISCL. Update on erythrodermic cutaneous T-cell lymphoma: report of the international society for cutaneous lymphomas. J. Am. Acad. Dermatol. 2002; 46(1): 95-106.
- Sigurdsson V., Toonstra J., Hezemenas-Boer M., van Vloten W.A. Erythrodema: a clinical and follow-up study of 102 patients, with special emphasis on survival. J. Am. Acad. Dermatol. 1996; 35(1): 53-7.
- Dubrey S.W., Rosser G., Patel K., Whittaker S.J. Erythroderma is not all psoriasis: a case of Sezary syndrome. Br. J. Hosp. Med. (Lond). 2014; 75(1): 50-1.
- Ram-Wolff C., Martin-Garcia N., Bensussan A., Bagot M., Ortonne N. Histopathologic diagnosis of lymphomatous versus inflammatory erythroderma: a morphologic and phenotypic study on 47 skin biopsies. Am. J. Dermatopathol. 2010; 32(8): 755-63.
- Заславский Д.В., Чупров И.Н., Сыдиков А.А., Ибрагимов К.У., Волькенштейн П., Скрек С.В., Насыров Р.А. Роль маркера IL-36γ/IL-1F9 в развитии эритродермии у пациентов с псориазом. Казанский медицинский журнал. 2015; 1: 80-4.
- D’Erme A.M., Wilsmann-Theis D., Wagenpfeil J., Holzel M., Ferring-Schmitt S., Sternberg S., et al. IL-36gamma (IL-1F9) is a biomarker for psoriasis skin lesions. J. Invest. Dermatol. 2015; 135(4): 1025-32.
- Wenzel J., Worenkamper E., Freutel S., Henze S., Haller O., Bieber T., et al. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. J. Pathol. 2005; 205(4): 435-42.
- Dinarello C., Arend W., Sims J., Smith D., Blumberg H., O’Neill L., et al. IL-1 family nomenclature. Nat. Immunol. 2010; 11(11): 973. doi: 10.1038/ni1110-973
- Vigne S., Palmer G., Lamacchia C., Martin P., Talabot-Ayer D., Rodriguez E., et al. IL-36R ligands are potent regulators of dendritic and T cells. Blood. 2011; 118(22): 5813-23.
- Marrakchi S., Guigue P., Renshaw B.R., Puel A., Pei X.Y., Fraitag S., et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N. Engl. J. Med. 2011; 365(7): 620-8.
- Foster A.M., Baliwag J., Chen C.S., Guzman A.M., Stoll S.W., Gudjonsson J.E., et al. IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin. J. Immunol. 2014; 192(12): 6053-61.
- Li N., Yamasaki K., Saito R., Fukushi-Takahashi S., Shimada-Omori R., Asano M., et al. Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36gamma induction in human epidermal keratinocytes. J. Immunol. 2014; 193(10): 5140-8.